What we do
Future Fund: Breakthrough
Future Fund: Breakthrough is £375m UK-wide programme which encourages private investors to co-invest in high-growth, innovative firms.
The programme makes equity co-investments with private sector investors in growth stage R&D-intensive British companies operating in breakthrough technology sectors. The minimum total investment round size is £30m. The maximum Future Fund: Breakthrough share of an investment round is 30%.
It is a separate programme to the now closed Future Fund that provided convertible loans, valued up to £5m, to a broad range of innovative companies to address the funding challenges caused by Covid-19.
Key features
- Focused on R&D-intensive companies
- Minimum total investment round size of £30m
- Companies must have raised at least £5m in previous funding rounds
- Companies must be UK based with significant UK operations
- The application must be made by a sponsor investor
Investment process
Sponsor investor begins application via the website
Assessment of sponsor investor eligibility
Introduction of British Patient Capital to company by sponsor investor
Assessment of company and transaction eligibility
Preliminary assessment by Investment Committee
Find out more
Potential sponsor investorsThis link takes you to a dedicated page for Investors wishing to find out more about Future Fund: Breakthrough and companies can find more information, including eligibility criteria and the application form.
If you have any queries please contact breakthrough@bpcinv.co.uk Email for queries dedicated to Future Fund: Breakthrough
For more information, please read our
